Rituximab-containing reduced-intensity conditioning improves progression-free survival following allogeneic transplantation in B cell non-Hodgkin lymphoma

BACKGROUND: In B cell non-Hodgkin lymphoma (B-NHL), rituximab-containing reduced-intensity conditioning regimens (R-RIC) have been shown to provide favorable outcomes in single-arm studies; however, large multicenter studies comparing R-RIC and non-rituximab-containing reduced-intensity conditioning...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Hematol Oncol
Main Authors: Epperla, Narendranath, Ahn, Kwang Woo, Ahmed, Sairah, Jagasia, Madan, DiGilio, Alyssa, Devine, Steven M., Jaglowski, Samantha, Kennedy, Vanessa, Rezvani, Andrew R., Smith, Sonali M., Sureda, Anna, Fenske, Timothy S., Kharfan-Dabaja, Mohamed A., Armand, Phillipe, Hamadani, Mehdi
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5469142/
https://ncbi.nlm.nih.gov/pubmed/28606176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-017-0487-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados